FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis
Status:
Completed
Trial end date:
2017-06-13
Target enrollment:
Participant gender:
Summary
This is a randomized, multicenter, double-blind, placebo-controlled study of the treatment of
anemia in subjects with CKD not on dialysis, with treatment up to 52 weeks.